Xpert MTB/RIF test for tuberculosis

The Lancet

Volumn 378, Issue 9790, 2011, Pages 481-

  Theron, Grant ^a   Peter, Jonny ^a   Dheda, Keertan ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC TEST; FALSE NEGATIVE RESULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MIXED INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 79961239433     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61242-7     Document Type: Letter

References (4)

1. CC Boehme, MP Nicol, P Nabeta et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study Lancet 377 2011 1495 1505
2. G Theron, J Peter, R van Zyl-Smit et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting Am J Respir Crit Care Med 184 2011 132 140
3. Stop TB Department WHO Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB http://www.who.int/tb/laboratory/roadmap-xpert-mtb- rif.pdf (accessed July 18, 2011).
4. Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) Report of the tenth meeting http://www.who.int/tb/advisory-bodies/stag-tb-report-2010. pdf (accessed July 18, 2011).